NEKTAR THERAPEUTICS (NKTR) has 351 open-market insider trades by 23 insiders since 2006. Over the last six months insiders net sold $86K. The most active filer is Howard W. Robin, CEO & President.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Howard W. Robin | CEOPres | — | 69 | $88.0M | 2026-08-18 |
| John Nicholson | COOVP | — | 19 | $42.3M | 2019-08-16 |
| Stephen K. Doberstein | CSOVP | — | 20 | $34.5M | 2019-09-05 |
| Gil M. Labrucherie | COOCFOVP | — | 42 | $28.7M | 2022-05-16 |
| Jillian B. Thomsen | CAOVP | — | 39 | $12.8M | 2023-02-16 |
| Maninder Hora | VP | — | 17 | $9.6M | 2019-05-16 |
| Robert Chess | Dir | — | 26 | $7.9M | 2026-09-23 |
| Jonathan Zalevsky | — | — | 31 | $7.1M | 2026-08-18 |
| Christopher A. Kuebler | Dir | — | 6 | $6.5M | 2018-09-27 |
| Lutz Lingnau | Dir | — | 11 | $5.9M | 2020-09-22 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Howard W. Robin | CEO & President | Sell | $30K | 2026-08-18 |
| Jonathan Zalevsky | — | Sell | $13K | 2026-08-18 |
| Jonathan Zalevsky | — | Sell | $398K | 2026-06-30 |
| Howard W. Robin | CEO & President | Sell | $1.2M | 2026-06-16 |
| Jonathan Zalevsky | — | Sell | $336K | 2026-06-15 |
| Howard W. Robin | CEO & President | Sell | $29K | 2026-05-19 |
Companies that share insiders with NKTR, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| Jonathan Zalevsky | — | Sell | $13K | 2026-05-19 |
| Howard W. Robin | President | Sell | $31K | 2026-02-18 |
| Jonathan Zalevsky | Chief R&D Officer | Sell | $13K | 2026-02-18 |
| Jonathan Zalevsky | Chief R&D Officer | Sell | $138K | 2026-01-20 |
| Mark Andrew Wilson | CLO | Sell | $34K | 2025-11-25 |
| Jonathan Zalevsky | — | Sell | $126K | 2025-11-25 |
| Howard W. Robin | CEO & President | Sell | $240K | 2025-11-25 |
| Howard W. Robin | CEO & President | Sell | $528K | 2025-09-09 |
| Howard W. Robin | CEO & President | Sell | $755K | 2025-09-04 |